Science Explorer Back to mapMap
Discussion
Institution · Asklepios Klinik St. Georg

Most cited papers from Asklepios Klinik St. Georg

Asklepios Klinik St. Georg

What are the most cited papers from Asklepios Klinik St. Georg?

The most cited paper from Asklepios Klinik St. Georg is "2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation" (Hugh G Calkins et al., 2017), with 2,780 citations. Next come "Autopsy Findings and Venous Thromboembolism in Patients With COVID-19" (2,391) and "Early Rhythm-Control Therapy in Patients with Atrial Fibrillation" (2,193).

Showing 50 of 57 papers. Every paper with more than 384 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation Hugh G Calkins et al. · Heart Rhythm Open access 12 May 2017 2,780
2 Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 Dominic Wichmann et al. · Annals of Internal Medicine Open access 6 May 2020 2,391
3 Early Rhythm-Control Therapy in Patients with Atrial Fibrillation Paulus F. Kirchhof et al. · New England Journal of Medicine Open access 29 Aug 2020 2,193
4 Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation Karl-Heinz Kuck, Josép Brugada, Alexander Fürnkranz et al. · New England Journal of Medicine Open access 4 Apr 2016 1,960
5 Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection Nezam H. Afdhal et al. · New England Journal of Medicine Open access 12 Apr 2014 1,718
6 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design Hugh G Calkins et al. · Journal of Interventional Cardiac Electrophysiology 28 Feb 2012 1,689
7 Brown adipose tissue activity controls triglyceride clearance Alexander Bartelt, Oliver T. Bruns†, Rudolph Reimer et al. · Nature Medicine 23 Jan 2011 1,642
8 Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction Stefan Hans Hohnloser, Karl Heinz Kuck, Paul Dorian et al. · New England Journal of Medicine 9 Dec 2004 1,528
9 Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation Douglas L. Packer et al. · JAMA Open access 15 Mar 2019 1,517
10 Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest Karl-Heinz Kuck, Riccardo Cappato, Jürgen Siebels et al. · Circulation 15 Aug 2000 1,485
11 Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation NASSIR F. MARROUCHE, David J. Wilber, Gerhard Hindricks et al. · JAMA 4 Feb 2014 1,449
12 Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group W. Hiddemann · Blood Open access 26 Aug 2005 1,327
13 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up Hugh Calkins et al. · EP Europace Open access Jun 2007 1,299
14 Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Michael G. Pfreundschuh et al. · The Lancet Oncology 17 Jan 2008 1,139
15 Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer Joachim von Pawel, Joan H. Schiller, Frances Alice Shepherd et al. · Journal of Clinical Oncology Feb 1999 965
16 Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves Danny Dvir et al. · JAMA Open access 8 Jul 2014 921
17 Percutaneous Mitral Valve Interventions in the Real World Francesco Maisano, Olaf Walter Franzen, Stephan Ernst Baldus et al. · Journal of the American College of Cardiology Open access 7 Jun 2013 838
18 Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins Feifan Ouyang, Matthias Antz, Sabine Ernst et al. · Circulation 29 Dec 2004 804
19 Extracorporeal Life Support in Infarct-Related Cardiogenic Shock Hölger Thiele et al. · New England Journal of Medicine Open access 26 Aug 2023 802
20 Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial Karl‐Heinz Kück, Anselm Schaumann, Lars Eckardt et al. · The Lancet 2010 801
21 EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias Etienne Aliot, William G. Stevenson, Jesus Ma Almendral-Garrote et al. · Heart Rhythm 24 May 2009 772
22 European Resuscitation Council Guidelines 2021: Epidemiology of cardiac arrest in Europe Jan‐Thorsten Gräsner, Johan D. Herlitz, Ingvild Beathe Myrhaugen Tjelmeland et al. · Resuscitation 24 Mar 2021 770
23 Complete Isolation of Left Atrium Surrounding the Pulmonary Veins Feifan Ouyang, Dietmar Bänsch, Sabine Ernst et al. · Circulation Open access 4 Oct 2004 762
24 Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis Deepak L. Bhatt, Kim Allen Eagle, E. Magnus Ohman et al. · JAMA 31 Aug 2010 756
25 Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL Michael G. Pfreundschuh · Blood Open access 16 Mar 2004 723
26 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary Hugh G Calkins et al. · Journal of Arrhythmia Open access 15 Sep 2017 711
27 Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation Feifan Ouyang, Roland Richard Tilz, Julian Chun et al. · Circulation Open access 23 Nov 2010 708
28 Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement Mohamed Abdel‐Wahab, Julinda Mehilli, Christian Frerker et al. · JAMA 30 Mar 2014 692
29 Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2) Carlos Arturo Morillo, Atul Verma, Stuart J. Connolly et al. · JAMA Open access 18 Feb 2014 673
30 Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group Norbert Schmitz, Lorenz H. P. Trümper, Marita Ziepert et al. · Blood Open access 21 Jul 2010 605
31 Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions Gregg W. Stone, David H Adams, William T. Abraham et al. · Journal of the American College of Cardiology Open access Jul 2015 589
32 IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome Laura Belloni, Lena Allweiss, Francesca Guerrieri et al. · Journal of Clinical Investigation Open access 17 Jan 2012 579
33 Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage Joji B. Kuramatsu et al. · JAMA 24 Feb 2015 568
34 Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp Feifan Ouyang, Parwis C. Fotuhi, Siew Yen Ho et al. · Journal of the American College of Cardiology Open access Feb 2002 562
35 Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study Armando Santoro et al. · The Lancet Oncology 19 Nov 2012 558
36 MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma Heike Horn, Marita Ziepert, Claudia Becher et al. · Blood 18 Jan 2013 547
37 The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes Maria Grazia Bongiorni, Charles E.H. Kennergren, Christian Butter et al. · European Heart Journal Open access 15 Feb 2017 498
38 Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis Sung-Han Yoon et al. · Journal of the American College of Cardiology Open access 18 Mar 2017 492
39 The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study Vivek Yerrapu Reddy, Dipen C. Shah, Josef Kautzner et al. · Heart Rhythm Open access 20 Jul 2012 489
40 Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study Emmanuel Ekanem et al. · Nature Medicine Open access139 authors Jul 2024 484
41 Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation Maurizio Taramasso et al. · Journal of the American College of Cardiology Open access 27 Sep 2019 480
42 Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation Nicola Gökbuget, Daniel Stanze, Joachim Beck et al. · Blood Open access 5 Apr 2012 477
43 Catheter Ablation of Long-Standing Persistent Atrial Fibrillation Roland Richard Tilz, Andreas Rillig, Anna-Maria Thum et al. · Journal of the American College of Cardiology Open access 10 Oct 2012 473
44 Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions Jean Fajadet, William C. Wijns, GertJan Laarman et al. · Circulation Open access 14 Aug 2006 465
45 Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial Lucas V.A. Boersma, Hueseyin Ince, Stephan Kische et al. · Heart Rhythm Open access Jun 2017 439
46 Electrical Reconnection After Pulmonary Vein Isolation Is Contingent on Contact Force During Initial Treatment Petr Neužil, Vivek Yerrapu Reddy, Josef Kautzner et al. · Circulation Arrhythmia and Electrophysiology 21 Mar 2013 438
47 Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study Peter Reimer, Thomas Rüdiger, Eva Geissinger et al. · Journal of Clinical Oncology 24 Nov 2008 426
48 Performance of a New Leadless Implantable Cardiac Monitor in Detecting and Quantifying Atrial Fibrillation Results of the XPECT Trial Gerhard Hindricks, Evgeny A. Pokushalov, Ľuboš Urban et al. · Circulation Arrhythmia and Electrophysiology 17 Feb 2010 426
49 Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines Vincent Grégoire et al. · Radiotherapy and Oncology Open access 24 Nov 2017 414
50 Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial Shaji Kunnathu Kumar, Simon James Harrison, Michèle Cavo et al. · The Lancet Oncology 30 Oct 2020 412

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.